- Home
- HYFM vs ADVB Comparison
HYFM vs ADVB Comparison
Compare HYFM & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HYFM
- ADVB
- Stock Information
- Founded
- HYFM 1977
- ADVB 2014
- Country
- HYFM United States
- ADVB United States
- Employees
- HYFM N/A
- ADVB N/A
- Industry
- HYFM Industrial Machinery/Components
- ADVB Medical Specialities
- Sector
- HYFM Industrials
- ADVB Health Care
- Exchange
- HYFM Nasdaq
- ADVB Nasdaq
- Market Cap
- HYFM 11.2M
- ADVB 9.7M
- IPO Year
- HYFM 2020
- ADVB 2025
- Fundamental
- Price
- HYFM $1.78
- ADVB $0.43
- Analyst Decision
- HYFM
- ADVB
- Analyst Count
- HYFM 0
- ADVB 0
- Target Price
- HYFM N/A
- ADVB N/A
- AVG Volume (30 Days)
- HYFM 22.4K
- ADVB 2.2M
- Earning Date
- HYFM 11-12-2025
- ADVB 10-27-2025
- Dividend Yield
- HYFM N/A
- ADVB N/A
- EPS Growth
- HYFM N/A
- ADVB N/A
- EPS
- HYFM N/A
- ADVB N/A
- Revenue
- HYFM $146,443,000.00
- ADVB N/A
- Revenue This Year
- HYFM N/A
- ADVB N/A
- Revenue Next Year
- HYFM $37.86
- ADVB N/A
- P/E Ratio
- HYFM N/A
- ADVB N/A
- Revenue Growth
- HYFM N/A
- ADVB N/A
- 52 Week Low
- HYFM $1.50
- ADVB $0.34
- 52 Week High
- HYFM $8.55
- ADVB $4.10
- Technical
- Relative Strength Index (RSI)
- HYFM 24.83
- ADVB 44.97
- Support Level
- HYFM $1.74
- ADVB $0.39
- Resistance Level
- HYFM $2.47
- ADVB $0.46
- Average True Range (ATR)
- HYFM 0.20
- ADVB 0.06
- MACD
- HYFM -0.04
- ADVB -0.00
- Stochastic Oscillator
- HYFM 1.00
- ADVB 11.24
About HYFM Hydrofarm Holdings Group Inc.
Hydrofarm Holdings Group Inc is a distributor and manufacturer of agriculture equipment and supplies. Some of its products includes lighting solutions, growing media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies sold under proprietary, exclusive/preferred brands, or non-exclusive/distributed brands. The business is organized into two operating segments, the U.S. and Canada.
About ADVB Advanced Biomed Inc. Common Stock
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.